Skip to main navigation

Investor Relations

September 21, 2023
Abivax presents first-half 2023 financial results
September 07, 2023
Abivax provides business and operational update
August 23, 2023
Abivax appoints Patrick Malloy as Senior Vice President Investor Relations
August 21, 2023
Abivax secures up to EUR 150M from two structured debt financing transactions
August 10, 2023
Abivax announces plans to conduct registered public offering in the United States